← Open Payments lookup

CHRISTOPHER STALLARD: Open Payments

NPI 1134480908 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,478 in 117 payments from 16 companies in 2025. Trend: 2023 $2,478 · 2024 $2,562 · 2025 $2,478

Food & beverage: $2,342Education: $136
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP22$580
GlaxoSmithKline, LLC.28$408
Regeneron Healthcare Solutions, Inc.13$352
Verona Pharma, Inc.12$268
Boehringer Ingelheim Pharmaceuticals, Inc.15$259
GENZYME CORPORATION6$142
Insmed, Inc.6$120
Vifor Pharma, Inc.4$104
Takeda Pharmaceuticals U.S.A., Inc.3$75
Grifols USA, LLC2$47

Products named: DUPIXENT, NUCALA, Ohtuvayre, BREZTRI, TEZSPIRE, OFEV, TRELEGY ELLIPTA, Arikayce.

Industry payments across TX — which companies pay providers there.